Clinical Trial Recruitment for Breast Cancer with Genetic Modifier

A large, global pharmaceutical company enrolling a Phase 3 clinical trial in breast cancer with a genetic modifier engaged Seeker Health to create an engaging social media campaign to accelerate genetic testing, participant identification and clinical trial enrollment. 


the challenge

Our challenge: 

  1. Educate women with breast cancer about the availability of this clinical trial and the opportunity to receive genetic testing

  2. Accelerate clinical trial enrollment

The approach

Seeker Health developed a compliant Facebook campaign, focused on a subset of the Facebook user population which had previously taken actions that denoted an interest in breast cancer. 

To optimize the campaign outcomes, A/B testing of images, text and targeting were implemented.

Seeker Health deployed its tool for complete comment suppression on Facebook Newsfeed Ads to mitigate risk of user-generated misinformation. 

The results

  • 9,419 US patients engaged via Facebook advertising to begin online pre-screen


  • 866 US patients completed online prescreen and qualified for follow up by clinical trial sites


  • THREE months saved from enrollment timeline



We would love to help your company get outstanding results in clinical trial enrollment. Learn more about our process here, or contact us today.